Used in biochemical and pharmaceutical research as a key intermediate for developing targeted protein degradation therapies, particularly in the design of PROTACs (proteolysis-targeting chimeras). Its amine and amide functional groups allow for efficient conjugation to E3 ligase ligands and target protein binders, enabling selective degradation of disease-related proteins. Commonly employed in studies focused on cancer, neurodegenerative diseases, and inflammatory conditions due to its stability and linker compatibility in cellular systems.